Vibrio Infections On the Rise

Increases in oceanic populations of these bacteria—both pathogenic and not—is an effect of climate change, scientists show.

Written byAlison F. Takemura
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Vibrio choleraeWIKIMEDIA; TOM KIRN, RON TAYLOR, LOUISA HOWARDVibrio cholerae, V. vulnificus, and V. parahemolyticus can cause life-threatening infections. The risk they pose is also growing. As ocean temperatures have climbed over the last five decades, both Vibrio population sizes and infection rates have risen in regions the North Atlantic and the North Sea, according to a study published yesterday (August 8) in PNAS.

Scientists continue to observe an increase in outbreaks of marine infections—which can cause disease in humans, coral, and other organisms—as a result of changing ocean conditions. Researchers from the University of Genoa, Italy, and their international colleagues analyzed formalin-preserved plankton samples to determine changes in Vibrio abundances along the North Atlantic from 1958 to 2011.

Study coauthor Rita Colwell of the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, expressed concern, particularly for places that haven’t historically experienced high rates of Vibrio infections, such as the rapidly warming Baltic Sea in Northern Europe. “They are now reporting more Vibrio in their waters,” she told New Scientist. “Not because it wasn’t there before, but because the water was too cold [for them to bloom]. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies